Definitely enroll in the program if you were down there, even if you don't have any symptoms,' says Dominic D'Amico.

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...

They may cause temporary side effects: Some studies have found that using exosomes can cause temporary symptoms such as ...

Allstate offers pet insurance through Embrace. Embrace offers a customizable accident-and-illness plan with your choice of ...

Information on screening and risk reduction to help healthcare professionals support patients with urgent suspected cancer referrals.